Shingo Fujio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shingo Fujio has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Ryosuke Hanaya
Department of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima City, Japan
8 shared publications - Kazunori Arita
Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
7 shared publications - Koji Yoshimoto
Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
6 shared publications Masanori Yonenaga
Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
6 shared publicationsRyosuke Hanaya
Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University
6 shared publicationsKazunori Arita
Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
5 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (14)
Intraventricular black fungal hyphal masses caused by Cladophialophora bantiana: illustrative case
BACKGROUND: CNS fungal infections are rare, life-threatening conditions primarily affecting immunocompromised hosts. While they typically present as brain abscesses, intraventricular proliferation of fungal hyphae is exceedingly rare, and its neuroendoscopic findings have seldom been reported. OBSERVATIONS: A man in his 80s with a history of malignancies presented with a 1-month history of headache. Brain MRI showed contrast-enhancing lesions along the genu of corpus callosum and lateral ventricles, as well as a nonenhancing lesion protruding into the ventricles. Although these findings were atypical, an endoscopic biopsy was performed because the lesions showed a tendency to enlarge, raising suspicion of a malignant tumor. Neuroendoscopic examination revealed a black-pigmented intraventricular fungal mass, which was partially resected. Shotgun metagenomic analysis identified the pathogen as Cladophialophora bantiana . LESSONS: C. bantiana exhibits marked neurotropism and is known to cause CNS fungal infections even in immunocompetent individuals. Although intraventricular extension of phaeohyphomycosis is extremely rare and preoperative differential diagnosis remains challenging, a nonenhancing lesion protruding into the ventricles was considered to reflect the presence of fungal hyphae in this case. https://thejns.org/doi/10.3171/CASE26730
- 5 October 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (14)
Open AccessIntraventricular black fungal hyphal masses caused by Cladophialophora bantiana: illustrative case
BACKGROUND: CNS fungal infections are rare, life-threatening conditions primarily affecting immunocompromised hosts. While they typically present as brain abscesses, intraventricular proliferation of fungal hyphae is exceedingly rare, and its neuroendoscopic findings have seldom been reported. OBSERVATIONS: A man in his 80s with a history of malignancies presented with a 1-month history of headache. Brain MRI showed contrast-enhancing lesions along the genu of corpus callosum and lateral ventricles, as well as a nonenhancing lesion protruding into the ventricles. Although these findings were atypical, an endoscopic biopsy was performed because the lesions showed a tendency to enlarge, raising suspicion of a malignant tumor. Neuroendoscopic examination revealed a black-pigmented intraventricular fungal mass, which was partially resected. Shotgun metagenomic analysis identified the pathogen as Cladophialophora bantiana . LESSONS: C. bantiana exhibits marked neurotropism and is known to cause CNS fungal infections even in immunocompetent individuals. Although intraventricular extension of phaeohyphomycosis is extremely rare and preoperative differential diagnosis remains challenging, a nonenhancing lesion protruding into the ventricles was considered to reflect the presence of fungal hyphae in this case. https://thejns.org/doi/10.3171/CASE26730
- Open Access
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1) , vdag146
Possible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing
Background: Pituitary carcinoma is a rare tumor, accounting for 0.12% of pituitary neuroendocrine tumors (PitNETs), that is derived from adenohypophyseal cells with craniospinal or systemic metastasis. While most PitNETs have a benign course, pituitary carcinoma has a poor prognosis, and its underlying molecular mechanism remains unclear. Here, we explored the molecular pathogenesis of pituitary carcinoma using whole exome sequencing (WXS). Methods: Tumor tissue samples were collected from patients diagnosed with pituitary carcinoma from April 2000 to March 2024 through multi-institutional joint research. DNA extraction and WXS were performed on the collected samples, and we analyzed the obtained data. Results: Five samples from four patients were collected (four men, mean age 57.5 years). DNA extraction and WXS were performed on the five samples. Gene mutation analysis revealed MEN1 mutations in three samples. Copy number analysis showed unstable chromosomal conditions of genome-wide hypoploidy, which can be called near-haploidy, in three samples. Conclusions: This study showed that pituitary carcinoma had genome-wide hypoploidy, that is, genome-wide chromosomal instability and MEN1 mutations as a possible recurrent mutation. Accumulated or original chromosomal instability may lead to the development of pituitary carcinoma from PitNET, and MEN1 mutations may also play an important role in the pathogenesis of pituitary carcinoma. These findings may lead to strategies for earlier diagnosis and new treatments for this disease.
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1) , vdag146
Open AccessPossible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing
Background: Pituitary carcinoma is a rare tumor, accounting for 0.12% of pituitary neuroendocrine tumors (PitNETs), that is derived from adenohypophyseal cells with craniospinal or systemic metastasis. While most PitNETs have a benign course, pituitary carcinoma has a poor prognosis, and its underlying molecular mechanism remains unclear. Here, we explored the molecular pathogenesis of pituitary carcinoma using whole exome sequencing (WXS). Methods: Tumor tissue samples were collected from patients diagnosed with pituitary carcinoma from April 2000 to March 2024 through multi-institutional joint research. DNA extraction and WXS were performed on the collected samples, and we analyzed the obtained data. Results: Five samples from four patients were collected (four men, mean age 57.5 years). DNA extraction and WXS were performed on the five samples. Gene mutation analysis revealed MEN1 mutations in three samples. Copy number analysis showed unstable chromosomal conditions of genome-wide hypoploidy, which can be called near-haploidy, in three samples. Conclusions: This study showed that pituitary carcinoma had genome-wide hypoploidy, that is, genome-wide chromosomal instability and MEN1 mutations as a possible recurrent mutation. Accumulated or original chromosomal instability may lead to the development of pituitary carcinoma from PitNET, and MEN1 mutations may also play an important role in the pathogenesis of pituitary carcinoma. These findings may lead to strategies for earlier diagnosis and new treatments for this disease.
- Open Access
- 22 October 2025
- Published by Springer Nature in Pituitary
- Vol. 28 (6) , 1-12
Less invasive skull base reconstruction using gelatin sponge and collagen matrix to prevent cerebrospinal fluid leakage after endoscopic transsphenoidal surgery: experience in 558 cases
Purpose: We evaluated the effectiveness of a less invasive skull base reconstruction technique using a fibrin glue-soaked gelatin sponge (FGGS) and collagen matrix to prevent cerebrospinal fluid (CSF) leakage following endoscopic transsphenoidal surgery (ETSS). This approach minimizes the need for fascia harvesting and the use of nasoseptal flaps. Methods: We retrospectively analyzed data from 558 ETSS, excluding Rathke’s cleft cysts, performed at our institution. Surgeries were classified by intraoperative CSF leakage grade according to Esposito’s classification. Patients’ characteristics and intraoperative findings were analyzed to assess potential risk factors for postoperative CSF leakage. Postoperative CSF leakage rates were compared between the pre-collagen matrix (428 surgeries) and collagen matrix (130 surgeries) periods. Results: FGGS-based reconstruction without fat grafts was performed in 73.7% of surgeries, including 99.4% of grade 0 and 88.5% of grade 1 leaks. Nasoseptal flaps were used in only eight surgeries (1.4%), and fascia was not used at all, either for watertight dural suturing or for multilayer reconstruction. The overall postoperative CSF leakage rate was 1.8% (10/558). The leakage rates by intraoperative CSF leak grade were 0%, 1.7%, 5.6%, and 1.1% for grades 0, 1, 2, and 3, respectively. Postoperative CSF leakage was associated with unfamiliar techniques and excessive bucking during extubation. During the collagen matrix period, although 33.8% of surgeries involved grade 3 high-flow CSF leaks, only one surgery (0.8%; 1/130) resulted in postoperative CSF leakage. Conclusions: As a less invasive technique, skull base reconstruction using FGGS and/or a collagen matrix was effective in reducing postoperative CSF leakage.
- 22 October 2025
- Published by Springer Nature in Pituitary
- Vol. 28 (6) , 1-12
Open AccessLess invasive skull base reconstruction using gelatin sponge and collagen matrix to prevent cerebrospinal fluid leakage after endoscopic transsphenoidal surgery: experience in 558 cases
Purpose: We evaluated the effectiveness of a less invasive skull base reconstruction technique using a fibrin glue-soaked gelatin sponge (FGGS) and collagen matrix to prevent cerebrospinal fluid (CSF) leakage following endoscopic transsphenoidal surgery (ETSS). This approach minimizes the need for fascia harvesting and the use of nasoseptal flaps. Methods: We retrospectively analyzed data from 558 ETSS, excluding Rathke’s cleft cysts, performed at our institution. Surgeries were classified by intraoperative CSF leakage grade according to Esposito’s classification. Patients’ characteristics and intraoperative findings were analyzed to assess potential risk factors for postoperative CSF leakage. Postoperative CSF leakage rates were compared between the pre-collagen matrix (428 surgeries) and collagen matrix (130 surgeries) periods. Results: FGGS-based reconstruction without fat grafts was performed in 73.7% of surgeries, including 99.4% of grade 0 and 88.5% of grade 1 leaks. Nasoseptal flaps were used in only eight surgeries (1.4%), and fascia was not used at all, either for watertight dural suturing or for multilayer reconstruction. The overall postoperative CSF leakage rate was 1.8% (10/558). The leakage rates by intraoperative CSF leak grade were 0%, 1.7%, 5.6%, and 1.1% for grades 0, 1, 2, and 3, respectively. Postoperative CSF leakage was associated with unfamiliar techniques and excessive bucking during extubation. During the collagen matrix period, although 33.8% of surgeries involved grade 3 high-flow CSF leaks, only one surgery (0.8%; 1/130) resulted in postoperative CSF leakage. Conclusions: As a less invasive technique, skull base reconstruction using FGGS and/or a collagen matrix was effective in reducing postoperative CSF leakage.
- Open Access
- 15 May 2025
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 65 (5) , 217-229
Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review
Craniopharyngiomas are locally aggressive, rare tumors that pose significant treatment challenges and often result in permanent neurological deficits. Since the discovery of the BRAF V600E driver mutation in papillary craniopharyngioma, several case reports have reported on the efficacy of BRAF inhibitors or the combination of BRAF and MEK inhibitors in treating papillary craniopharyngiomas with this mutation. However, the efficacy, safety, and optimal utilization of this emerging therapy for craniopharyngiomas remain unclear. We conducted a systematic review of published articles in PubMed, Scopus, and the Cochrane Library-CENTRAL, focusing on the efficacy and safety of BRAF/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation, covering publications from inception through June 2024. A total of 20 case reports and series involving 22 patients were included in the analysis. Combination therapy with BRAF/MEK inhibitors was employed in 81.8% of cases. Significant tumor reduction (≥80%) was observed in 18 of 21 cases, regardless of radiation therapy history, pretargeted therapy tumor volume, and tumor composition. The duration of tumor minimization ranged from 1 to 24 months (median: 5 months). Fever was the most commonly reported adverse event (28.6%), followed by dermatological symptoms (19%). Tumor recurrence was noted in 4 of 6 patients who did not receive additional treatment following the completion of targeted therapy; however, targeted therapy was effective in the cases in which it was resumed. This study provides critical insights into optimizing treatment strategies for papillary craniopharyngiomas and underscores the potential role of targeted therapies in enhancing patient outcomes.
- 15 May 2025
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 65 (5) , 217-229
Open AccessProspects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review
Craniopharyngiomas are locally aggressive, rare tumors that pose significant treatment challenges and often result in permanent neurological deficits. Since the discovery of the BRAF V600E driver mutation in papillary craniopharyngioma, several case reports have reported on the efficacy of BRAF inhibitors or the combination of BRAF and MEK inhibitors in treating papillary craniopharyngiomas with this mutation. However, the efficacy, safety, and optimal utilization of this emerging therapy for craniopharyngiomas remain unclear. We conducted a systematic review of published articles in PubMed, Scopus, and the Cochrane Library-CENTRAL, focusing on the efficacy and safety of BRAF/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation, covering publications from inception through June 2024. A total of 20 case reports and series involving 22 patients were included in the analysis. Combination therapy with BRAF/MEK inhibitors was employed in 81.8% of cases. Significant tumor reduction (≥80%) was observed in 18 of 21 cases, regardless of radiation therapy history, pretargeted therapy tumor volume, and tumor composition. The duration of tumor minimization ranged from 1 to 24 months (median: 5 months). Fever was the most commonly reported adverse event (28.6%), followed by dermatological symptoms (19%). Tumor recurrence was noted in 4 of 6 patients who did not receive additional treatment following the completion of targeted therapy; however, targeted therapy was effective in the cases in which it was resumed. This study provides critical insights into optimizing treatment strategies for papillary craniopharyngiomas and underscores the potential role of targeted therapies in enhancing patient outcomes.
- Open Access
- 18 February 2025
- Published by Springer Nature in Pituitary
- Vol. 28 (2) , 1-11
Prevalence and risk of complications in untreated patients with adult growth hormone deficiency
Purpose: Adult growth hormone deficiency (AGHD) increases the prevalence of complications, including metabolic disorder, leading to increased cardiovascular mortality from cardiovascular diseases. However, no large database studies have evaluated AGHD patients without GH replacement therapy (GHRT). We investigated the prevalence of AGHD-related complications in patients without GHRT. Methods: Patients with AGHD and associated complications were identified from the Medical Data Vision claims database using Japanese local disease codes mapped to ICD-10 codes. The prevalence of AGHD-related complications in 2020 was estimated to compare with the prevalence in the Japanese general population in the latest available year 2020. Risk factors for complications were evaluated by Kaplan-Meier curves and a Cox proportional hazard model. Results: We identified 8,809 untreated patients with AGHD from April 2008 to September 2022, including 3,430 in 2020. In 2020, the prevalence of complications was higher in the AGHD population adjusted for sex and age than in the Japanese general population, e.g., diabetes mellitus, 9.3% vs. 3.6%; osteoporosis, 4.8% vs. 1.3%; and dyslipidemia, 22.0% vs. 3.9%. Age was a significant risk factor for most complications, and female sex for osteoporosis. Diabetes mellitus was a significant risk factor for dyslipidemia, ischemic heart disease, cerebrovascular disease, and all-cause death. Conclusion: Untreated patients with AGHD have a higher prevalence of metabolic complications than the general population despite no difference in their related risk factors. Given the low use of GHRT in this study, comprehensive treatment approaches that include GHRT need to be considered to alleviate the risk of complications.
- 18 February 2025
- Published by Springer Nature in Pituitary
- Vol. 28 (2) , 1-11
Open AccessPrevalence and risk of complications in untreated patients with adult growth hormone deficiency
Purpose: Adult growth hormone deficiency (AGHD) increases the prevalence of complications, including metabolic disorder, leading to increased cardiovascular mortality from cardiovascular diseases. However, no large database studies have evaluated AGHD patients without GH replacement therapy (GHRT). We investigated the prevalence of AGHD-related complications in patients without GHRT. Methods: Patients with AGHD and associated complications were identified from the Medical Data Vision claims database using Japanese local disease codes mapped to ICD-10 codes. The prevalence of AGHD-related complications in 2020 was estimated to compare with the prevalence in the Japanese general population in the latest available year 2020. Risk factors for complications were evaluated by Kaplan-Meier curves and a Cox proportional hazard model. Results: We identified 8,809 untreated patients with AGHD from April 2008 to September 2022, including 3,430 in 2020. In 2020, the prevalence of complications was higher in the AGHD population adjusted for sex and age than in the Japanese general population, e.g., diabetes mellitus, 9.3% vs. 3.6%; osteoporosis, 4.8% vs. 1.3%; and dyslipidemia, 22.0% vs. 3.9%. Age was a significant risk factor for most complications, and female sex for osteoporosis. Diabetes mellitus was a significant risk factor for dyslipidemia, ischemic heart disease, cerebrovascular disease, and all-cause death. Conclusion: Untreated patients with AGHD have a higher prevalence of metabolic complications than the general population despite no difference in their related risk factors. Given the low use of GHRT in this study, comprehensive treatment approaches that include GHRT need to be considered to alleviate the risk of complications.
- Open Access
- 11 October 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 372
A pituitary gland squeezed upward by intrasellar kissing carotid arteries: Mimicking a pituitary microadenoma
Background: Intrasellar kissing carotid arteries are a rare variant in which bilateral internal carotid arteries run very near each other at their cavernous sinus portion. We encountered a woman with the pituitary gland mimicking a pituitary microadenoma because the pituitary gland was compressed bilaterally by intrasellar kissing carotid arteries. Case Description: A 61-year-old woman with a chronic headache underwent magnetic resonance imaging, which revealed a sellar mass measuring 10.2 mm in height, 8.2 mm in length, and 4.0 mm in width at the midintercarotid level. Blood levels of all pituitary and target-organ hormones were within normal range. The height and superior convex shape of the sellar mass suggested that it was a nonfunctioning microadenoma, which was monitored over the past 16 years. A recent three-dimensional reconstruction of magnetic resonance angiography clearly showed that the pituitary gland was squeezed upward, compressed bilaterally, and extended superiorly by intrasellar kissing carotid arteries. Conclusion: The pituitary gland can be squeezed upward by intrasellar kissing carotid arteries and mimic pituitary tumor.
- 11 October 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 372
Open AccessA pituitary gland squeezed upward by intrasellar kissing carotid arteries: Mimicking a pituitary microadenoma
Background: Intrasellar kissing carotid arteries are a rare variant in which bilateral internal carotid arteries run very near each other at their cavernous sinus portion. We encountered a woman with the pituitary gland mimicking a pituitary microadenoma because the pituitary gland was compressed bilaterally by intrasellar kissing carotid arteries. Case Description: A 61-year-old woman with a chronic headache underwent magnetic resonance imaging, which revealed a sellar mass measuring 10.2 mm in height, 8.2 mm in length, and 4.0 mm in width at the midintercarotid level. Blood levels of all pituitary and target-organ hormones were within normal range. The height and superior convex shape of the sellar mass suggested that it was a nonfunctioning microadenoma, which was monitored over the past 16 years. A recent three-dimensional reconstruction of magnetic resonance angiography clearly showed that the pituitary gland was squeezed upward, compressed bilaterally, and extended superiorly by intrasellar kissing carotid arteries. Conclusion: The pituitary gland can be squeezed upward by intrasellar kissing carotid arteries and mimic pituitary tumor.
- Open Access
- 30 August 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 307
CT correlation of spinal canal diameter with pedicle size for safer posterior cervical pedicle screw fixation
Background: Utilizing computed tomography (CT) studies, we correlated cervical spinal canal diameters (SCDs) with pedicle size between the C3 and C7 levels to more safely perform posterior cervical surgery. Methods: We retrospectively analyzed CT studies for 71 patients with cranial or spinal disorders and correlated the cervical SCD with the pedicle outer width (POW) between the C3 and C7 levels. Patients were divided into normal (SCD ≥12 mm at any level, n = 30) and stenosis groups (SCD n = 41). Results: C7 exhibited the largest SCD and POW values, while C3 and C4 exhibited the smallest SCD and POW values. Moderate correlations (r = 0.3, P = 0.002) were observed at the C3 and C4 levels but no significant correlations were observed from the C5 to C7 levels. For SCD values, the normal group demonstrated significantly greater values between the C3 and C7 levels versus the stenosis group. For POW values, only the C4 level differed significantly between the two groups (P = 0.014, Mann–Whitney U-test). Conclusion: Preoperative pedicle size evaluation remains an essential manoeuvre before performing cervical C3–C7 pedicle screw placement. In 71 cervical CT studies, we found no consistent correlation between POW and SCD values, indicating that it is difficult to estimate POW values based on spinal canal size.
- 30 August 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 307
Open AccessCT correlation of spinal canal diameter with pedicle size for safer posterior cervical pedicle screw fixation
Background: Utilizing computed tomography (CT) studies, we correlated cervical spinal canal diameters (SCDs) with pedicle size between the C3 and C7 levels to more safely perform posterior cervical surgery. Methods: We retrospectively analyzed CT studies for 71 patients with cranial or spinal disorders and correlated the cervical SCD with the pedicle outer width (POW) between the C3 and C7 levels. Patients were divided into normal (SCD ≥12 mm at any level, n = 30) and stenosis groups (SCD n = 41). Results: C7 exhibited the largest SCD and POW values, while C3 and C4 exhibited the smallest SCD and POW values. Moderate correlations (r = 0.3, P = 0.002) were observed at the C3 and C4 levels but no significant correlations were observed from the C5 to C7 levels. For SCD values, the normal group demonstrated significantly greater values between the C3 and C7 levels versus the stenosis group. For POW values, only the C4 level differed significantly between the two groups (P = 0.014, Mann–Whitney U-test). Conclusion: Preoperative pedicle size evaluation remains an essential manoeuvre before performing cervical C3–C7 pedicle screw placement. In 71 cervical CT studies, we found no consistent correlation between POW and SCD values, indicating that it is difficult to estimate POW values based on spinal canal size.
- Open Access
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3)
Gamma Knife Radiosurgery: An Adjuvant Therapy for Primary Sellar Paraganglioma
Sellar paraganglioma (SP) is a rare benign tumor, usually treated by surgery. SPs are lobulated, firm, adherent, and highly vascular, allowing mostly partial resection. We present the case of a 52-year-old man diagnosed with primary SP, treated with a transcranial-transsphenoidal (TC-TS) surgical approach, followed by adjuvant Gamma Knife stereotactic radiosurgery (GKSR). The tumor has an extra-pituitary origin, with a sellar-suprasellar, right cavernous sinus extension that encroached the bilateral optic nerve and anterior cerebral artery. Histopathology confirmed SP with a Zellballen pattern. Despite postoperative tumor growth observed at four and 10 months, a stable residual tumor was noted at a follow-up two years after GKSR. SP is diagnosed mainly in middle age or in adolescent males. The TC-TS approach offers a bidirectional view that allows greater resection by minimizing blind spots, thus reducing complications. Similar to the paragangliomas of other sites, the efficacy of GKSR was observed for primary SP. SP is a rare differential diagnosis of pituitary diseases; however, it should be considered. After surgical resection of primary SP, GKSR is observed as an effective adjuvant therapy.
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3)
Open AccessGamma Knife Radiosurgery: An Adjuvant Therapy for Primary Sellar Paraganglioma
Sellar paraganglioma (SP) is a rare benign tumor, usually treated by surgery. SPs are lobulated, firm, adherent, and highly vascular, allowing mostly partial resection. We present the case of a 52-year-old man diagnosed with primary SP, treated with a transcranial-transsphenoidal (TC-TS) surgical approach, followed by adjuvant Gamma Knife stereotactic radiosurgery (GKSR). The tumor has an extra-pituitary origin, with a sellar-suprasellar, right cavernous sinus extension that encroached the bilateral optic nerve and anterior cerebral artery. Histopathology confirmed SP with a Zellballen pattern. Despite postoperative tumor growth observed at four and 10 months, a stable residual tumor was noted at a follow-up two years after GKSR. SP is diagnosed mainly in middle age or in adolescent males. The TC-TS approach offers a bidirectional view that allows greater resection by minimizing blind spots, thus reducing complications. Similar to the paragangliomas of other sites, the efficacy of GKSR was observed for primary SP. SP is a rare differential diagnosis of pituitary diseases; however, it should be considered. After surgical resection of primary SP, GKSR is observed as an effective adjuvant therapy.
- Open Access
- 1 March 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 69
Secondary hypophysitis associated with Rathke’s cleft cyst resembling a pituitary abscess
Background: Although rare, cases of hypophysitis resembling a pituitary abscess (PA) have been reported. Differential diagnosis between hypophysitis and PA is crucial as the two diseases require different treatments.Case Description: A 38-year-old woman with headaches underwent head magnetic resonance imaging (MRI), which revealed an 11-mm mass lesion in the sella turcica. Due to breastfeeding, contrast-enhanced MRI was avoided. Pituitary adenomas and Rathke’s cleft cyst (RCC) were suspected, and she was initially treated conservatively. Five months later, she acquired syndrome coronavirus two infections, and while the fever subsided with acetaminophen, the headache persisted. One month later, the headache worsened, followed by fever and diabetes insipidus. MRI revealed a pituitary cystic mass with ring-shaped contrast enhancement on T1-weighted MRI and increased signal intensity on diffusion-weighted imaging (DWI). PA was suspected, and emergency endoscopic transsphenoidal surgery was performed. The microbiological examination of the yellowish-brown content drained from the cystic mass was negative. Microscopically, the cystic lesion was covered with ciliated columnar epithelium and stratified squamous epithelium, with a dense inflammatory cell infiltrate consisting mainly of lymphocytes and plasma cells observed around the cyst. This supported the diagnosis of secondary hypophysitis associated with RCC without PA.Conclusion: We report a case of hypophysitis secondary to RCC resembling PA with ring-shaped contrast enhancement on MRI and increased signal intensity on DWI. This case emphasizes the need for cautious diagnosis of secondary hypophysitis due to RCC in individuals with MRIs and clinical manifestations resembling an abscess.
- 1 March 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 69
Open AccessSecondary hypophysitis associated with Rathke’s cleft cyst resembling a pituitary abscess
Background: Although rare, cases of hypophysitis resembling a pituitary abscess (PA) have been reported. Differential diagnosis between hypophysitis and PA is crucial as the two diseases require different treatments.Case Description: A 38-year-old woman with headaches underwent head magnetic resonance imaging (MRI), which revealed an 11-mm mass lesion in the sella turcica. Due to breastfeeding, contrast-enhanced MRI was avoided. Pituitary adenomas and Rathke’s cleft cyst (RCC) were suspected, and she was initially treated conservatively. Five months later, she acquired syndrome coronavirus two infections, and while the fever subsided with acetaminophen, the headache persisted. One month later, the headache worsened, followed by fever and diabetes insipidus. MRI revealed a pituitary cystic mass with ring-shaped contrast enhancement on T1-weighted MRI and increased signal intensity on diffusion-weighted imaging (DWI). PA was suspected, and emergency endoscopic transsphenoidal surgery was performed. The microbiological examination of the yellowish-brown content drained from the cystic mass was negative. Microscopically, the cystic lesion was covered with ciliated columnar epithelium and stratified squamous epithelium, with a dense inflammatory cell infiltrate consisting mainly of lymphocytes and plasma cells observed around the cyst. This supported the diagnosis of secondary hypophysitis associated with RCC without PA.Conclusion: We report a case of hypophysitis secondary to RCC resembling PA with ring-shaped contrast enhancement on MRI and increased signal intensity on DWI. This case emphasizes the need for cautious diagnosis of secondary hypophysitis due to RCC in individuals with MRIs and clinical manifestations resembling an abscess.
- 23 November 2023
- Published by Springer Nature in Neurosurgical Review
- Vol. 46 (1) , 1-8
Indocyanine green endoscopic evaluation of pituitary stalk and gland blood flow in craniopharyngiomas
To assess the use of indocyanine green (ICG) fluorescence endoscopy to evaluate pituitary blood flow in craniopharyngioma resection and its possible impact on intraoperative decisions regarding pituitary stalk processing. Patients with craniopharyngiomas who had undergone transsphenoidal surgery since March 2021, when an ICG endoscope was introduced at the Kagoshima University Hospital, were included in the study. When targeted tumor removal was approaching completion, 10 mg of ICG was administered intravenously to evaluate blood flow in the pituitary stalk and gland. ICG signals and endocrinological status before and after surgery were evaluated retrospectively. Pituitary stalk and gland blood flow were evaluated as positive (++), weakly positive (+), and no signal (−).Ten patients with craniopharyngiomas underwent transsphenoidal surgery using an ICG endoscope (mean age 56.6 ± 14.2 years; 40% male). Among the eight patients in whom the pituitary stalk was preserved, pituitary function with positive signal on the stalk was intact in two. Two other patients with weakly positive stalk and positive pituitary gland signals showed intact function or minimal pituitary dysfunction. Four patients had impairments in more than three axes with poor ICG signals in the stalk or pituitary gland. Two patients underwent pituitary amputation because of high tumor invasion and lack of ICG signal in the stalk after tumor removal, resulting in panhypopituitarism. A negative ICG signal in the pituitary stalk is likely to indicate postoperative pituitary function loss. Craniopharyngioma surgery using ICG endoscopy may be useful for predicting endocrine prognosis and improving tumor outcomes.
- 23 November 2023
- Published by Springer Nature in Neurosurgical Review
- Vol. 46 (1) , 1-8
Indocyanine green endoscopic evaluation of pituitary stalk and gland blood flow in craniopharyngiomas
To assess the use of indocyanine green (ICG) fluorescence endoscopy to evaluate pituitary blood flow in craniopharyngioma resection and its possible impact on intraoperative decisions regarding pituitary stalk processing. Patients with craniopharyngiomas who had undergone transsphenoidal surgery since March 2021, when an ICG endoscope was introduced at the Kagoshima University Hospital, were included in the study. When targeted tumor removal was approaching completion, 10 mg of ICG was administered intravenously to evaluate blood flow in the pituitary stalk and gland. ICG signals and endocrinological status before and after surgery were evaluated retrospectively. Pituitary stalk and gland blood flow were evaluated as positive (++), weakly positive (+), and no signal (−).Ten patients with craniopharyngiomas underwent transsphenoidal surgery using an ICG endoscope (mean age 56.6 ± 14.2 years; 40% male). Among the eight patients in whom the pituitary stalk was preserved, pituitary function with positive signal on the stalk was intact in two. Two other patients with weakly positive stalk and positive pituitary gland signals showed intact function or minimal pituitary dysfunction. Four patients had impairments in more than three axes with poor ICG signals in the stalk or pituitary gland. Two patients underwent pituitary amputation because of high tumor invasion and lack of ICG signal in the stalk after tumor removal, resulting in panhypopituitarism. A negative ICG signal in the pituitary stalk is likely to indicate postoperative pituitary function loss. Craniopharyngioma surgery using ICG endoscopy may be useful for predicting endocrine prognosis and improving tumor outcomes.